An Open-label, Multi-center, Phase 2 Study of Denosumab

Project: Research project

Project Details

Description

An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Tumor of Bone
StatusFinished
Effective start/end date9/5/0812/31/19

Funding

  • Amgen Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.